DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Systolic hypertension in older persons.

Author(s): Applegate WB

Affiliation(s): University of Tennessee, School of Medicine, Memphis.

Publication date & source: 1992, Adv Intern Med., 37:37-54.

Publication type: Clinical Trial; Randomized Controlled Trial; Review

In summary, elevated levels of SBP are the single greatest cardiovascular risk factor in patients over 65 years of age. Adequate clinical data exist to indicate that ISH can be treated effectively with a minimum amount of side effects in most elderly patients. The SHEP main trial has now definitely proved that treating ISH lowers cerebrovascular coronary heart disease, and total cardiovascular morbidity and mortality. See Table 3 for antihypertensive treatment recommendations in elderly patients.

Page last updated: 2007-05-02

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017